McKesson Corporation is a leading healthcare services and information technology company that specializes in the distribution of pharmaceuticals and medical supplies. The company provides a comprehensive range of services that enhance the efficiency of healthcare systems, including drug distribution to pharmacies, hospitals, and other healthcare providers. Additionally, McKesson offers innovative solutions for managing medical costs, optimizing inventory, and improving patient care through data analytics and technology. By ensuring the timely delivery of critical medical products and services, McKesson plays a vital role in the healthcare ecosystem, supporting both providers and patients. Read More
McKesson Corp (MCK) shows strong growth fundamentals and a promising technical breakout setup, making it a potential growth stock pick with upside potential.
Growth is oxygen.
But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
Healthcare distributor and services company McKesson (NYSE:MCK)
will be reporting results this Wednesday after market close. Here’s what investors should know.
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $0.82 per share of common stock, a 15% increase from $0.71 per share in the prior quarter. The dividend will be payable on October 1, 2025, to stockholders of record on September 2, 2025.
MCKESSON CORP (NYSE:MCK) offers strong growth in healthcare distribution with reasonable valuation and solid financial health, making it a candidate for growth-at-a-price investors.
Synergy CHC Corp. (NASDAQ: SNYR) is capturing national attention with the announcement of a strategic distribution partnership with McKesson Canada, a division of McKesson Corporation (NYSE: MCK) . The agreement gives FOCUSfactor® direct access to thousands of pharmacies and health-focused retailers across Canada, igniting the next phase of its aggressive North American expansion.
MCKESSON CORP (NYSE:MCK) shows strong growth fundamentals and a bullish technical setup, making it a stock to watch. The company's solid financials and breakout potential suggest further upside.
McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2026 financial results after market close on Wednesday, August 6, 2025. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
MCKESSON CORP (NYSE:MCK) meets Minervini’s Trend Template with strong technicals and high growth fundamentals, making it a stock to watch for momentum investors.
A cash-heavy balance sheet is often a sign of strength, but not always.
Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
McKesson Corporation (NYSE: MCK) announced it will host an Investor Day on Tuesday, September 23, 2025, in New York City. The event will feature presentations by McKesson’s leadership team followed by a Q&A session with chief executive officer Brian Tyler and chief financial officer Britt Vitalone. Management will provide an update on the company’s strategic priorities, growth strategies, and business outlook.
Healthcare distributor and services company McKesson (NYSE:MCK) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 18.9% year on year to $90.82 billion. Its non-GAAP profit of $10.12 per share was 3% above analysts’ consensus estimates.
Wall Street’s bearish price targets for the stocks in this article signal serious concerns.
Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
McKesson currently trades at $712.18 and has been a dream stock for shareholders. It’s returned 332% since June 2020, blowing past the S&P 500’s 83.5% gain. The company has also beaten the index over the past six months as its stock price is up 18%.
